- Home
- MDU vs CPRX Comparison
MDU vs CPRX Comparison
Compare MDU & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDU | CPRX |
|---|---|---|
| Founded | 1924 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 2.9B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | MDU | CPRX |
|---|---|---|
| Price | $19.61 | $23.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $22.00 | ★ $32.60 |
| AVG Volume (30 Days) | ★ 2.3M | 1.2M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | ★ 2.85% | N/A |
| EPS Growth | N/A | ★ 44.94 |
| EPS | 0.82 | ★ 1.71 |
| Revenue | ★ $1,876,593,000.00 | $578,196,000.00 |
| Revenue This Year | $9.10 | $19.87 |
| Revenue Next Year | $3.08 | $7.21 |
| P/E Ratio | $21.78 | ★ $13.83 |
| Revenue Growth | N/A | ★ 25.56 |
| 52 Week Low | $15.04 | $19.05 |
| 52 Week High | $21.49 | $26.58 |
Technical Indicators
Market Signals| Indicator | MDU | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.85 | 62.17 |
| Support Level | $19.22 | $22.20 |
| Resistance Level | $19.71 | $23.84 |
| Average True Range (ATR) | 0.33 | 0.60 |
| MACD | -0.17 | -0.06 |
| Stochastic Oscillator | 17.41 | 91.01 |
Price Performance
Historical ComparisonAbout MDU MDU Resources Group Inc. (Holding Company)
MDU Resources Group Inc operates in three business segments, which include the electric segment, which generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming; The natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington; The pipeline segment provides natural gas transportation and underground storage services through a regulated pipeline system in the Rocky Mountain and northern Great Plains regions of the United States.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).